Bradfordhill ( Site 0300)

Santiago, Region M. de Santiago 8420383

2 studies enrolling now · 2 studies all time

What they study most

Gastrointestinal Cancer, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02) — Recruiting now
• Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) — Recruiting now